Table 2.
Clinical stage (pre-treatment) | Pathological stage (after surgery) | |
---|---|---|
Patient 1 | cT4N2M1 | ypT2N0M0 |
Patient 2 | cT4N3M1 | ypT0N0M0 |
Patient 3 | cT4N2M1 | ypT1N0M0 |
Patient 4 | cT4N3M1 | ypT0N0M0 |
cTNM classification was evaluated based on the Chinese Gastric Cancer Treatment Guidelines before any treatment (pre-treatment). ypTNM classification was evaluated according the Chinese Gastric Cancer Treatment Guidelines after radical resection (after surgery). cTNM, clinical tumor stage before neoadjuvant therapy; ypTNM, pathological tumor stage after neoadjuvant therapy